Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chlamydia pneumoniae respiratory infections.

Francesco Blasi1, Roberto Cosentini, Paolo Tarsia

  • 1aInstitute of Respiratory Diseases, University of Milan, IRCCS Ospedale Maggiore di Milano, and bDepartment of Emergency Medicine, IRCCS Ospedale Maggiore di Milano, Italy.

Current Opinion in Infectious Diseases
|April 20, 2002
PubMed
Summary

Chlamydia pneumoniae causes respiratory infections, from mild to severe pneumonia and bronchitis. This bacterium is increasingly linked to asthma and affects immunocompromised individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical outcomes of bronchiectasis in India: data from the EMBARC/Respiratory Research Network of India registry.

The European respiratory journal·2022
Same author

The Prescribing Practice for COPD: Relationship to Circadian Rhythm, Disease Severity, and Clinical Phenotype in the STORICO Observational Study.

Advances in therapy·2022
Same author

The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study.

American journal of hematology·2022
Same author

Corrigendum to 'External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019'.

European journal of internal medicine·2022
Same author

Lung Transplant for ARDS after COVID-19: Long-Term Outcomes and Considerations about Detrimental Issues.

Journal of clinical medicine·2022
Same author

Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study.

Internal and emergency medicine·2022

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Chlamydia pneumoniae is a common bacterial pathogen.
  • It is a significant etiological agent of respiratory tract infections.
  • The clinical manifestations vary widely, from subclinical infections to severe respiratory distress.

Purpose of the Study:

  • To summarize the spectrum of diseases caused by Chlamydia pneumoniae.
  • To highlight the emerging roles of C. pneumoniae in specific patient populations.
  • To underscore the importance of C. pneumoniae in respiratory medicine.

Main Methods:

  • Literature review of studies on Chlamydia pneumoniae infections.
  • Analysis of clinical case reports and epidemiological data.

Related Experiment Videos

  • Synthesis of current evidence on C. pneumoniae pathogenesis and clinical impact.

    • Main Results:

    • C. pneumoniae causes a range of respiratory illnesses, including pneumonia and chronic bronchitis exacerbations.
    • Evidence supports C. pneumoniae's involvement in bronchial asthma pathogenesis.
    • The role of C. pneumoniae in immunocompromised patients is increasingly recognized.

    Conclusions:

    • Chlamydia pneumoniae is a versatile respiratory pathogen with a broad clinical spectrum.
    • Further research is warranted to elucidate the mechanisms of C. pneumoniae in asthma and immunocompromised states.
    • Effective management strategies for C. pneumoniae infections remain crucial in respiratory care.